These data drew our attention to the role of C-lectin members in cancer inhibition such as the negative role of CLEC3B in the development of cancers [21], and cell apoptosis promotion due to CLEC14A overexpression in lung adenocarcinoma (LUAD) [56]. Here, CLEC3B is linked to lung adenocarcinoma.